Giuliano Marchetti

Dr. Giuliano Marchetti

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
WHWalid Habre
Walid Habre
NDNicola Disma
Nicola Disma
KVKatalin Virag
Katalin Virag
KBKarin Becke
Karin Becke
MJMartin Jöhr
Martin Jöhr
PHPierre Harlet
Pierre Harlet

27 April 2020 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
JLJerrold Lerman
Jerrold Lerman
MCMarco Cascella
Marco Cascella
AGAndrea D. Gomez-Morad
Andrea D. Gomez-Morad
GMGiuliano Marchetti
Giuliano Marchetti
SPSergio G. Picardo
Sergio G. Picardo

27 July 2021 in Children
Verified
Journal Article
Open access
PDF file
GMGiuliano Marchetti
Giuliano Marchetti
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
FFFabio Ferrari
Fabio Ferrari
EFElisa Francia
Elisa Francia
IMIlaria Mascilini
Ilaria Mascilini
SPSergio Giuseppe Picardo
Sergio Giuseppe Picardo
We studied acute and chronic pain in pediatric patients who underwent thoracotomy for benign disease with a follow-up of at least three months. A telephone interview investigated about the presence of pain and the analgesic therapy in progress. The results were compared with the anesthetic technique, postoperative pain and the adequacy of pain therapy, both during the first week after surgery and at the time of interview. Fifty-six families consented to the study. The mean age of the children at surgery was 2.9 ± 4.5 years, while at the time of the interview was 6.5 ± 4.4 years. We performed different anesthetic strategies: Group A: general anesthesia (36 pts); Group B: general anesthesia and thoracic epidural (10 pts); Group C: general anesthesia and intercostal nerve block (10 pts). During the immediate postoperative period, 21 patients (37.5%) had at least one painful episode. At the time of interview, 3 children (5.3%) had moderate chronic neuropathic (burning) pain on surgical scar. There was no statistically significant difference between the type of anesthesia and the incidence and severity of acute post-operative pain. Despite its limitations, this study confirms the low incidence of chronic post-thoracotomy pain syndrome in children.

16 November 2016
Verified
Journal Article
Closed access
GMGiuliano Marchetti
Giuliano Marchetti
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
VTV Tortora
V Tortora
MBM Bishop
M Bishop
GLG Lofino
G Lofino
SPS Picardo
S Picardo

6 May 2020 in Acupuncture in Medicine
Verified
Journal Article
Closed access
PDF file
GMGiuliano Marchetti
Giuliano Marchetti
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
IMIlaria Mascilini
Ilaria Mascilini
EFElisa Francia
Elisa Francia
SPSergio Giuseppe Picardo
Sergio Giuseppe Picardo

27 February 2026 in Children
Verified
Journal Article
Open access
PDF file
Alessandro VittoriAlessandro Vittori
Alessandro Vittori
CFCecilia Di Fabio
Cecilia Di Fabio
EFElisa Francia
Elisa Francia
IMIlaria Mascilini
Ilaria Mascilini
RTRiccardo Tarquini
Riccardo Tarquini
MCMarco Cascella
Marco Cascella
Remimazolam is an ultra-short-acting benzodiazepine developed according to the “soft drug” concept and characterized by rapid onset, predictable offset, organ-independent metabolism, and the availability of a specific antagonist. Due to these pharmacological features, this drug represents a particularly attractive option for pediatric anesthesia and sedation, a field in which traditional agents are often limited by hemodynamic instability, prolonged recovery, and adverse respiratory effects. This narrative review summarizes and discusses the current evidence regarding the use of remimazolam in pediatric patients, focusing on pharmacokinetics, pharmacodynamics, clinical applications, and safety. Available data indicate that remimazolam provides effective sedation and anesthesia in children across multiple settings, including induction of general anesthesia, non-operating room anesthesia, and intensive care unit sedation. Compared with propofol and midazolam, remimazolam is generally associated with greater hemodynamic stability, rapid recovery, reduced emergence delirium, and a favorable respiratory profile, while maintaining comparable efficacy. Intranasal administration has also shown promise as a premedication strategy for reducing preoperative anxiety, although it may occasionally be associated with pain. Even if remimazolam lacks intrinsic analgesic properties, its use appears to indirectly improve postoperative comfort by attenuating stress responses and emergence agitation. Despite encouraging results, pediatric use of remimazolam remains off-label in many countries, and evidence is still limited by small sample sizes and heterogeneous protocols. Further large-scale randomized controlled trials are needed to define optimal dosing strategies, long-term safety, and their definitive role in pediatric anesthetic and sedative practice.